Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan · Delayed Price · Currency is JPY 1,041.00
-4.00 (-0.38%)
Aug 27, 2026, 3:30 PM JST
TYO:6039 Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 13,506 | 15,121 | 6,679 | 5,179 | 4,977 | 4,188 | |
Market Cap Growth | 29.66% | 126.40% | 28.97% | 4.06% | 18.84% | -15.14% |
Enterprise Value | 17,412 | 17,249 | 9,297 | 7,720 | 6,841 | 5,810 |
Last Close Price | 1045.00 | 1170.00 | 511.70 | 380.85 | 352.27 | 349.37 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.13 | 18.15 | 12.84 | 15.37 | 13.10 | 14.64 |
Forward PE | 13.31 | 15.51 | 11.63 | 12.70 | 12.70 | 12.70 |
PS Ratio | 2.12 | 2.44 | 1.27 | 1.21 | 1.29 | 1.41 |
PB Ratio | 2.72 | 3.10 | 1.61 | 1.36 | 1.34 | 1.67 |
P/TBV Ratio | 3.14 | 3.50 | 1.82 | 1.59 | 1.61 | 2.10 |
P/FCF Ratio | - | - | 15.98 | - | 60.69 | - |
P/OCF Ratio | 9.68 | 10.84 | 4.87 | 5.76 | 6.14 | 7.52 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.74 | 2.79 | 1.76 | 1.81 | 1.77 | 1.95 |
EV/EBITDA Ratio | 9.50 | 9.93 | 7.20 | 8.03 | 6.90 | 8.53 |
EV/EBIT Ratio | 14.04 | 15.00 | 12.89 | 15.53 | 11.80 | 13.20 |
EV/FCF Ratio | - | - | 22.24 | - | 83.43 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.04 | 1.06 | 0.84 | 1.01 | 1.07 | 1.56 |
Debt / EBITDA Ratio | - | 2.97 | 2.69 | 4.01 | 4.01 | 5.76 |
Debt / FCF Ratio | - | - | 8.31 | - | 48.48 | - |
Net Debt / Equity Ratio | 0.79 | 0.73 | 0.57 | 0.66 | 0.56 | 1.14 |
Net Debt / EBITDA Ratio | 2.13 | 2.05 | 1.83 | 2.62 | 2.08 | 4.19 |
Net Debt / FCF Ratio | - | -3.74 | 5.66 | -17.86 | 25.11 | -64.84 |
Asset Turnover | 0.63 | 0.62 | 0.60 | 0.49 | 0.50 | 0.47 |
Inventory Turnover | 32.68 | 39.41 | 36.07 | 25.17 | 19.13 | 19.61 |
Quick Ratio | 0.48 | 0.52 | 0.92 | 1.06 | 1.71 | 1.34 |
Current Ratio | 0.54 | 0.56 | 1.03 | 1.16 | 1.89 | 1.60 |
Return on Equity (ROE) | 19.43% | 18.45% | 13.07% | 8.97% | 12.23% | 11.81% |
Return on Assets (ROA) | 7.63% | 7.16% | 5.14% | 3.58% | 4.66% | 4.29% |
Return on Invested Capital (ROIC) | 14.33% | 11.22% | 8.12% | 5.64% | 7.43% | 6.24% |
Return on Capital Employed (ROCE) | 15.90% | 15.20% | 10.00% | 6.90% | 7.90% | 7.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.61% | 5.51% | 7.79% | 6.51% | 7.63% | 6.83% |
FCF Yield | -7.06% | -6.31% | 6.26% | -2.72% | 1.65% | -1.05% |
Dividend Yield | 1.27% | 1.03% | 1.45% | 1.05% | - | - |
Payout Ratio | - | 12.01% | 10.19% | - | - | - |
Buyback Yield / Dilution | -0.05% | 0.34% | 6.73% | -11.92% | -2.18% | 0.26% |
Total Shareholder Return | 1.22% | 1.37% | 8.17% | -10.87% | -2.18% | 0.26% |